Exousia Bio, Inc. (LMMY) stock
Close on Oct 19, 2026Market cap $175.47KP/E –Yield –
What Exousia Bio keeps of every dollar
Trailing twelve months, from revenue down to net income. Grey columns are what comes out.
What it earns on the capital it uses
Trailing twelve months over average capital
How hard the assets work
The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.
How fast it is growing
Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years
What it owes and what covers it
Latest balance sheet, against twelve months of cash generation
Leverage and liquidity
The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.
Scores and rules of thumb
Academic scores computed from the latest two fiscal years. They are screens, not verdicts.
Piotroski F-Score
Nine yes-or-no tests of profit, leverage and efficiency against last year.
3 of 9 tests passed
How the shares have traded
Total return includes reinvested dividends, to the close on Oct 19, 2026
Total return against the S&P 500
The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.
| Period | LMMY | S&P 500 | Difference | LMMY per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -10.6% | +0.6% | −11.3 pts | ||
| 3 months | -96.7% | +3.4% | −100.1 pts | ||
| Year to date | -95.4% | +13.3% | −108.7 pts | ||
| 1 year | -92.1% | +16.6% | −108.7 pts |
Who is betting against it
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date May 15, 2026.
0M LMMY shares were sold short on May 15, 2026, up 0.0% from the previous report. At recent volumes it would take 1.0 days to buy them back.
The last twelve reports
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| May 15, 2026 | 10 | 0.0% | 1,577 | 1.0 |
| Apr 30, 2026 | 10 | – | 638 | 1.0 |
| Dec 31, 2025 | 0 | -100.0% | 2,249 | 0.0 |
| Dec 15, 2025 | 50 | – | 13,617 | 1.0 |
| Jun 13, 2025 | 1,440 | – | 7,303 | 1.0 |
| May 15, 2025 | 2,200 | -83.8% | 40,705 | 1.0 |
| Apr 30, 2025 | 13,622 | +6711.0% | 114,309 | 1.0 |
| Apr 15, 2025 | 200 | 0.0% | 54,534 | 1.0 |
| Mar 31, 2025 | 200 | +900.0% | 3,545 | 1.0 |
| Mar 14, 2025 | 20 | – | 2,836 | 1.0 |
Every measure, in full
28 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Feb 28, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 54.7%
- 0.13%
- Shares Change (QoQ)
- 0.00%
- 0.00%
- Float
- 53M
- 22M
- Shares Held by Insiders
- 0.00%
- 15.8%
Returns on capitalIndustry
- Return on Equity (ROE)
- -0.73%
- 3.71%
- Return on Assets (ROA)
- -0.73%
- -2.87%
Financial positionIndustry
- Current Ratio
- 0.00
- 1.63
- Quick Ratio
- 0.00
- 0.87
GrowthIndustry
- Revenue Growth (YoY)
- -100.0%
- 3.64%
- Net Income Growth (YoY)
- -160.4%
- 5.84%
- EPS Growth (YoY)
- -100.0%
- 10.7%
EfficiencyIndustry
- Asset Turnover
- 0.00
- 0.83
Income statement (TTM)Industry
- Pretax Income
- -$80.16K
- -$27.47K
Balance sheetIndustry
- Net Cash (Debt)
- $0
- $2.65M
- Net Cash Per Share
- $0.00
- $0.18
- Equity (Book Value)
- $21.79M
- $19.21M
- Book Value Per Share
- $0.42
- $2.72
- Tangible Book Value
- $21.79M
- $12.05M
- Working Capital
- -$261.02K
- $5.41M
Cash flow (TTM)Industry
Taxes and interestIndustry
- Income Tax
- $0
- $1.27M
Scores and fair valueIndustry
- Piotroski F-Score
- 3
- 4
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?